Joseph C. Galante - 14 Apr 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Joseph C. Galante by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
14 Apr 2022
Net transactions value
+$1,673
Form type
4
Filing time
06 May 2022, 17:07:23 UTC
Previous filing
29 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $152 +56 +0.12% $2.71 45,117 14 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $147 +56 +0.12% $2.63 45,173 18 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $151 +56 +0.12% $2.69 45,229 19 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +56 +0.12% $2.74 45,285 20 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $154 +56 +0.12% $2.75 45,341 21 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +56 +0.12% $2.73 45,397 22 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $160 +61 +0.13% $2.62 45,458 25 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $154 +61 +0.13% $2.53 45,519 26 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $147 +61 +0.13% $2.41 45,580 27 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $153 +61 +0.13% $2.51 45,641 28 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $149 +61 +0.13% $2.44 45,702 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.